Substrate and product analogues as human O-GlcNAc transferase inhibitors

Amino Acids

Volumn 40, Issue 3, 2011, Pages 781-792

  Dorfmueller, Helge C ^a   Borodkin, Vladimir S ^a   Blair, David E ^a   Pathak, Shalini ^a   Navratilova, Iva ^a   Van Aalten, Daan M F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Crystal structure; Inhibitor; O GlcNAc; Post translational modification; Signalling

Indexed keywords

ALLOXAN; N ACETYLGLUCOSAMINE TRANSFERASE; N ACETYLGLUCOSAMINE TRANSFERASE INHIBITOR; TRANSFERASE; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG BINDING; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ACETYLGLUCOSAMINE; ENZYME INHIBITORS; GLYCOSYLATION; HUMANS; KINETICS; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEIN BINDING; PROTEINS; SUBSTRATE SPECIFICITY;

METAZOA;

EID: 79954429001     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-010-0688-y     Document Type: Article

References (66)

1. C Abad-Zapatero JT Metz 2005 Ligand efficiency indices as guideposts for drug discovery Drug Discov Today 10 7 464 469 10.1016/S1359-6446(05)03386-6 15809192
2. S Banerjee PW Robbins J Samuelson 2009 Molecular characterization of nucleocytosolic O-GlcNAc transferases of Giardia lamblia and Cryptosporidium parvum Glycobiology 19 4 331 336 1:CAS:528:DC%2BD1MXivFSnurs%3D 10.1093/glycob/cwn107 18948359
3. L Bialy H Waldmann 2004 Total synthesis and biological evaluation of the protein phosphatase 2A inhibitor cytostatin and analogues Chemistry 10 11 2759 2780 1:CAS:528:DC%2BD2cXkvFGhtbo%3D 10.1002/chem.200305543 15195307
4. Blair D, Borodkin V, Gray L, van Aalten D (manuscript submitted)
5. SA Caldwell SR Jackson KS Shahriari TP Lynch G Sethi S Walker K Vosseller MJ Reginato 2010 Nutrient sensor it O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1 Oncogene 29 2831 2842 1:CAS:528:DC%2BC3cXisFOkt7s%3D 10.1038/onc.2010.41 20190804
6. R Chang T Vo N Finney 2006 Synthesis of the C1-phosphonate analog of UDP-GlcNAc Carbohydr Res 341 1998 2004 1:CAS:528:DC%2BD28XmvFerur0%3D 10.1016/j.carres.2006.05.008 16750179
7. TY Chou GW Hart 2001 O-linked N-acetylglucosamine and cancer: messages from the glycosylation of c-Myc Adv Exp Med Biol 491 413 418 1:CAS:528:DC%2BD3sXns1aqt7k%3D 14533811 (Pubitemid 32595138)
8. AJ Clarke R Hurtado-Guerrero S Pathak AW Schuttelkopf V Borodkin SM Shepherd AFM Ibrahim DMF van Aalten 2008 Structural insights into mechanism and specificity of O-GlcNAc transferase EMBO J 27 20 2780 2788 1:CAS:528: DC%2BD1cXht1KrtLnF 10.1038/emboj.2008.186 18818698
9. SB Cohen RL Halcomb 2000 Synthesis and characterization of an anomeric sulfur analogue of CMP-sialic acid J Org Chem 65 19 6145 6152 1:CAS:528:DC%2BD3cXlslKitL0%3D 10.1021/jo000646+ 10987952
10. N Comtesse E Maldener E Meese 2001 Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a β-N-acetylglucosaminidase Biochem Biophys Res Commun 283 3 634 640 1:CAS:528:DC%2BD3MXjt1Gns7k%3D 10.1006/bbrc.2001.4815 11341771 (Pubitemid 32917936)
11. RJ Copeland JW Bullen Jr GW Hart 2008 Crosstalk between glconacylation and phosphorylation: roles in insulin resistance and glucose toxicity Am J Physiol Endocrinol Metab 295 17 28 10.1152/ajpendo.90281.2008
12. P Coutinho E Deleury G Davies B Henrissat 2003 An evolving hierarchical family classification for glycosyltransferases J Mol Biol 328 307 317 1:CAS:528:DC%2BD3sXislehtr4%3D 10.1016/S0022-2836(03)00307-3 12691742 (Pubitemid 36407576)
13. RJ Dennis EJ Taylor MS Macauley KA Stubbs JP Turkenburg SJ Hart GN Black DJ Vocadlo GJ Davies 2006 Structure and mechanism of a bacterial β-glucosaminidase having O-GlcNAcase activity Nat Struct Mol Biol 13 365 371 1:CAS:528:DC%2BD28Xjs1OrtL8%3D 10.1038/nsmb1079 16565725 (Pubitemid 43873509)
14. W Dias G Hart 2007 O-GlcNAc modification in diabetes and Alzheimer's disease Mol Biosyst 3 766 772 1:CAS:528:DC%2BD2sXhtFKlsLbI 10.1039/b704905f 17940659 (Pubitemid 47587186)
15. AC Donadio C Lobo M Tosina V de la Rosa M Martin-Rufian JA Campos-Sandoval JM Mates J Marquez FJ Alonso JA Segura 2008 Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells J Cell Biochem 103 3 800 811 1:CAS:528:DC%2BD1cXit1ShsrY%3D 10.1002/jcb.21449 17614351 (Pubitemid 351240616)
16. DLY Dong GW Hart 1994 Purification and characterization of an O-GlcNAc selective N-acetyl-β-d-glucosaminidase from rat spleen cytosol J Biol Chem 269 19321 19330 1:CAS:528:DyaK2cXltValu7k%3D 8034696
17. HC Dorfmueller VS Borodkin M Schimpl SM Shepherd NA Shpiro DMF van Aalten 2006 GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-GlcNAcylation levels J Am Chem Soc 128 16484 16485 1:CAS:528:DC%2BD28XhtlWlsLzN 10.1021/ja066743n 17177381 (Pubitemid 46032711)
18. HC Dorfmueller VS Borodkin M Schimpl DMF van Aalten 2009 GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation Biochem J 420 2 221 227 1:CAS:528:DC%2BD1MXlvVGku7s%3D 10.1042/BJ20090110 19275764
19. P Emsley K Cowtan 2004 Coot: model-building tools for molecular graphics Acta Crystallogr Sect F Struct Biol Cryst Commun D60 2126 2132 1:CAS:528:DC%2BD2cXhtVars73P (Pubitemid 41742764)
20. E Ficko-Blean KJ Gregg JJ Adams J-H Hehemann M Czjzek SP Smith AB Boraston 2009 Portrait of an enzyme, a complete structural analysis of a multimodular beta-N-acetylglucosaminidase from Clostridium perfringens J Biol Chem 284 15 9876 9884 1:CAS:528:DC%2BD1MXjvFKrsrY%3D 10.1074/jbc.M808954200 19193644
21. ME Forsythe DC Love BD Lazarus EJ Kim WA Prinz G Ashwell MW Krause JA Hanover 2006 Caenorhabditis elegans ortholog of a diabetes susceptibility locus: OGA-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer Proc Natl Acad Sci USA 103 11952 11957 1:CAS:528:DC%2BD28XosVSgsbs%3D 10.1073/pnas.0601931103 16882729 (Pubitemid 44215792)
22. Y Gao L Wells FI Comer GJ Parker GW Hart 2001 Dynamic O-glycosylation of nuclear and cytosolic proteins-cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain J Biol Chem 276 9838 9845 1:CAS:528:DC%2BD3MXis1Oksr4%3D 10.1074/jbc.M010420200 11148210
23. LS Griffith B Schmitz 1995 O-linked N-acetylglucosamine is upregulated in Alzheimer brains Biochem Biophys Res Commun 213 2 424 431 1:CAS:528: DyaK2MXnsFKitrY%3D 10.1006/bbrc.1995.2149 7646495
24. BJ Gross BC Kraybill S Walker 2005 Discovery of O-GlcNAc transferase inhibitors J Am Chem Soc 127 14588 14589 1:CAS:528:DC%2BD2MXhtVeqtLjK 10.1021/ja0555217 16231908 (Pubitemid 41510995)
25. J Hajduch G Nam E Kim R Fraehlich J Hanover K Kirk 2008 A convenient synthesis of the C-1-phosphonate analogue of UDP-GlcNAc and its evaluation as an inhibitor of O-linked GlcNAc transferase (OGT) Carbohydr Res 343 189 195 1:CAS:528:DC%2BD1cXotlShsA%3D%3D 10.1016/j.carres.2007.10.027 18039537
26. R Haltiwanger M Blomberg G Hart 1992 Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide β-N-acetylglucosaminyltransferase J Biol Chem 267 9005 9013 1:CAS:528:DyaK38Xlt1Kqurs%3D 1533623
27. RS Haltiwanger K Grove GA Philipsberg 1998 Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-β-N-acetylglucosaminidase inhibitor O-(2-acetamido-2- deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate J Biol Chem 273 3611 3617 1:CAS:528:DyaK1cXhtVyms7c%3D 10.1074/jbc.273.6.3611 9452489 (Pubitemid 28109786)
28. JA Hanover MW Krause DC Love 2009 The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine Biochim Biophys Acta 1800 80 95 19647043
29. GW Hart MP Housley C Slawson 2007 Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins Nature 446 1017 1022 1:CAS:528:DC%2BD2sXksFersr4%3D 10.1038/nature05815 17460662 (Pubitemid 46676063)
30. R Hurtado-Guerrero HC Dorfmueller DMF van Aalten 2008 Molecular mechanisms of O-GlcNAcylation Curr Opin Struct Biol 18 5 551 557 1:CAS:528:DC%2BD1cXht1egu73E 10.1016/j.sbi.2008.09.005 18822376
31. SE Jacobsen KA Binkowski NE Olszewski 1996 SPINDLY, a tetratricopeptide repeat protein involved in gibberellin signal transduction in Arabidopsis Proc Natl Acad Sci USA 93 17 9292 9296 1:CAS:528:DyaK28Xlt1Cnu7w%3D 10.1073/pnas.93.17.9292 8799194 (Pubitemid 26282057)
32. E-S Kang D Han J Park TK Kwak M-A Oh S-A Lee S Choi ZY Park Y Kim JW Lee 2008 O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells Exp Cell Res 314 11-12 2238 2248 1:CAS:528: DC%2BD1cXns1Smt7c%3D 10.1016/j.yexcr.2008.04.014 18570920 (Pubitemid 351833109)
33. WG Kelly GW Hart 1989 Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin Cell 57 2 243 251 1:CAS:528:DyaL1MXit12js7Y%3D 10.1016/0092-8674(89)90962-8 2495182 (Pubitemid 19112364)
34. S Knapp D Myers 2001 Alpha-GlcNAc thioconjugates J Org Chem 66 3636 3638 1:CAS:528:DC%2BD3MXivFCjtLY%3D 10.1021/jo010088e 11348163 (Pubitemid 32878986)
35. RJ Konrad FX Zhang JE Hale MD Knierman GW Becker JE Kudlow 2002 Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase Biochem Biophys Res Commun 293 207 212 1:CAS:528:DC%2BD38XksVGitL0%3D 10.1016/S0006-291X(02)00200-0 12054585 (Pubitemid 34694192)
36. L Kreppel M Blomberg G Hart 1997 Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats J Biol Chem 272 9308 9315 1:CAS:528:DyaK2sXisVGqs7s%3D 10.1074/jbc.272.14.9308 9083067 (Pubitemid 27154943)
37. ST Laughlin CR Bertozzi 2009 In vivo imaging of caenorhabditis elegans glycans ACS Chem Biol 4 12 1068 1072 1:CAS:528:DC%2BD1MXhsFWrsr%2FO 10.1021/cb900254y 19954190
38. Leatherbarrow RJ (2001) GraFit. Version 5. Erithacus Software Ltd, Horley
39. S Lenzen R Munday 1991 Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin Biochem Pharmacol 42 7 1385 1391 1:CAS:528: DyaK3MXms12ru7c%3D 10.1016/0006-2952(91)90449-F 1930261
40. K Liu AJ Paterson E Chin JE Kudlow 2000 Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β-cells: linkage of O-linked GlcNAc to β-cell death Proc Natl Acad Sci USA 97 2820 2825 1:CAS:528:DC%2BD3cXitVahsbw%3D 10.1073/pnas.97.6.2820 10717000 (Pubitemid 30159255)
41. K Liu AJ Paterson RJ Konrad AF Parlow S Jimi M Roh EJ Chin JE Kudlow 2002 Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion Mol Cell Endocrinol 194 1-2 135 146 1:CAS:528:DC%2BD38XntVaqu70%3D 10.1016/S0303-7207(02)00155-7 12242036 (Pubitemid 35291928)
42. K Liu A Paterson F Zhang J McAndrew K Fukuchi J Wyss L Peng Y Hu J Kudlow 2004 Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism J Neurochem 89 1044 1055 1:CAS:528:DC%2BD2cXksVyktr8%3D 10.1111/j.1471-4159.2004.02389.x 15140202 (Pubitemid 38684749)
43. J Liu Y Yu YZ Fan H Chang HM Liu Y Cui Q Chen R Wang 2005 Cardiovascular effects of endomorphins in alloxan-induced diabetic rats Peptides 26 4 607 614 1:CAS:528:DC%2BD2MXitFyrtL8%3D 10.1016/j.peptides.2004.11.017 15752575 (Pubitemid 40326878)
44. J Liu Y Pang T Chang P Bounelis JC Chatham RB Marchase 2006 Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia J Mol Cell Cardiol 40 2 303 312 1:CAS:528:DC%2BD28XhtFSgsrg%3D 10.1016/j.yjmcc.2005.11.003 16337959 (Pubitemid 43152386)
45. J Liu RB Marchase JC Chatham 2007 Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels J Mol Cell Cardiol 42 1 177 185 1:CAS:528:DC%2BD2sXht1CmtQ%3D%3D 10.1016/j.yjmcc.2006.09. 015 17069847 (Pubitemid 44958621)
46. DC Love JA Hanover 2005 The hexosamine signaling pathway: deciphering the "O-GlcNAc code" Sci STKE 312 1 14
47. W Lubas D Frank M Krause J Hanover 1997 O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats J Biol Chem 272 9316 9324 1:CAS:528:DyaK2sXisVGqs7g%3D 10.1074/jbc.272.14.9316 9083068 (Pubitemid 27154944)
48. MS Macauley GE Whitworth AW Debowski D Chin DJ Vocadlo 2005 O-GlcNAcase uses substrate-assisted catalysis-kinetic analysis and development of highly selective mechanism-inspired inhibitors J Biol Chem 280 25313 25322 1:CAS:528:DC%2BD2MXlslyltL4%3D 10.1074/jbc.M413819200 15795231 (Pubitemid 40962233)
49. A Marlow L Kiessling 2001 Improved chemical synthesis of UDP-galactofuranose Org Lett 3 2517 2519 1:CAS:528:DC%2BD3MXltFSktrc%3D 10.1021/ol016170d 11483049 (Pubitemid 33627166)
50. C Martinez-Fleites M Macauley Y He D Shen D Vocadlo G Davies 2008 Structure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylation Nat Struct Mol Biol 15 764 765 1:CAS:528:DC%2BD1cXotVeqtrw%3D 10.1038/nsmb.1443 18536723 (Pubitemid 351932003)
51. DA McClain WA Lubas RC Cooksey M Hazel GJ Parker DC Love JA Hanover 2002 Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia Proc Natl Acad Sci USA 99 10695 10699 1:CAS:528: DC%2BD38Xmt1Chtro%3D 10.1073/pnas.152346899 12136128
52. GN Murshudov AA Vagin EJ Dodson 1997 Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr Sect F Struct Biol Cryst Commun D53 240 255 1:CAS:528:DyaK2sXjs1Gnsb4%3D (Pubitemid 27235885)
53. N Noach Y Segev I Levi S Segal E Priel 2007 Modification of topoisomerase I activity by glucose and by O-GlcNAcylation of the enzyme protein Glycobiology 17 12 1357 1364 1:CAS:528:DC%2BD2sXhtlejsrbJ 10.1093/glycob/cwm105 17932134 (Pubitemid 350131312)
54. T Pape TR Schneider 2004 HKL2MAP: a graphical user interface for macromolecular phasing with SHELX programs J Appl Crystallogr 37 843 844 1:CAS:528:DC%2BD2cXns1WjtLo%3D 10.1107/S0021889804018047
55. FV Rao HC Dorfmueller F Villa M Allwood IM Eggleston DMF van Aalten 2006 Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis EMBO J 25 1569 1578 1:CAS:528:DC%2BD28XjtFGqtLk%3D 10.1038/sj.emboj.7601026 16541109
56. AW Schuettelkopf DMF van Aalten 2004 PRODRG: a tool for high-throughput crystallography of protein-ligand complexes Acta Cryst D60 1355 1363 1:CAS:528:DC%2BD2cXlvVegtbY%3D (Pubitemid 41079731)
57. R Shafi SPN Lyer LG Ellies N O'Donnell KW Marek D Chui GW Hart JD Marth 2000 The O-GlcNAc transferase gene resides on the x chromosome and is essential for embryonic stem cell viability and mouse ontogeny Proc Natl Acad Sci USA 97 5735 5739 1:CAS:528:DC%2BD3cXjvFaktrY%3D 10.1073/pnas.100471497 10801981 (Pubitemid 30367467)
58. KA Stubbs N Zhang DJ Vocadlo 2006 A divergent synthesis of 2-acyl derivatives of PUGNAc yields selective inhibitors of O-GlcNAcase Org Biomol Chem 4 839 845 1:CAS:528:DC%2BD28Xhs1eqtLY%3D 10.1039/b516273d 16493467 (Pubitemid 43289794)
59. CR Torres GW Hart 1984 Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes - evidence for O-linked GlcNAc J Biol Chem 259 3308 3317 1:CAS:528: DyaL2cXhtlOhtr4%3D 6421821 (Pubitemid 14130544)
60. I Tvaroska 2004 Molecular modeling insights into the catalytic mechanism of the retaining galactosyltransferase LgtC Carbohydr Res 339 5 1007 1014 1:CAS:528:DC%2BD2cXhvV2gtb8%3D 10.1016/j.carres.2003.11.014 15010308 (Pubitemid 38316973)
61. L Wells GW Hart 2003 O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar FEBS Lett 546 154 158 1:CAS:528:DC%2BD3sXkvVKjsLo%3D 10.1016/S0014-5793(03) 00641-0 12829252 (Pubitemid 36782297)
62. W Yang J Kim H Nam J Ju H Kim Y Kim J Cho 2006 Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability Nat Cell Biol 8 1074 1083 1:CAS:528:DC%2BD28XhtVWqsLbN 10.1038/ncb1470 16964247 (Pubitemid 44473602)
63. P Yao P Coleman 1998 Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease J Neurosci 18 7 2399 2411 1:CAS:528:DyaK1cXitFequ7c%3D 9502801 (Pubitemid 28141789)
64. S Yuzwa M Macauley J Heinonen X Shan R Dennis Y He G Whitworth K Stubbs E McEachern G Davies D Vocadlo 2008 A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo Nat Chem Biol 4 483 490 1:CAS:528:DC%2BD1cXoslClsb4%3D 10.1038/nchembio.96 18587388
65. NE Zachara GW Hart 2004 O-GlcNAc modification: a nutritional sensor that modulates proteasome function Trends Cell Biol 14 218 221 1:CAS:528: DC%2BD2cXjvVemurs%3D 10.1016/j.tcb.2004.03.005 15130576 (Pubitemid 38591324)
66. NE Zachara WD Cheung GW Hart 2004 Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping Methods Mol Biol 284 175 194 1:CAS:528:DC%2BD2cXmsVamsLY%3D 15173616